Pemirolast potassium (formerly TWT 8152; BMY 26517; TWT-8152; BMY-26517; Alegysal and Alamast), the potassium salt of Pemirolast, is a poten and orally bioactive histamine H1 antagonist and mast cell stabilizer with potential antiallergic effects. For the treatment of asthma, a nonbronchodilator antiallergy medication candidate is being researched.
Physicochemical Properties
| Molecular Formula | C10H7KN6O |
| Molecular Weight | 266.3 |
| Exact Mass | 266.031 |
| Elemental Analysis | C, 45.10; H, 2.65; K, 14.68; N, 31.56; O, 6.01 |
| CAS # | 100299-08-9 |
| Related CAS # | Pemirolast; 69372-19-6 |
| PubChem CID | 443866 |
| Appearance | Light yellow to green yellow solid powder |
| Boiling Point | 454.8ºC at 760mmHg |
| Melting Point | 310-311ºC (dec.) |
| Flash Point | 228.9ºC |
| Vapour Pressure | 1.85E-08mmHg at 25°C |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 18 |
| Complexity | 495 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O=C1C(C2=N[N-]N=N2)=CN=C3N1C=CC=C3C.[K+] |
| InChi Key | NMMVKSMGBDRONO-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C10H7N6O.K/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8;/h2-5H,1H3;/q-1;+1 |
| Chemical Name | potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one |
| Synonyms | TWT-8152; BMY 26517; TWT 8152; BMY 26517; TWT8152; BMY 26517; Pemirolast; Pemirolast potassium. trade name: Alegysal and Alamast. |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Histamine H1 receptor | ||
| ln Vitro |
|
||
| ln Vivo |
|
||
| Animal Protocol |
|
||
| References |
[1]. Ann Allergy . 1992 Jun;68(6):488-91. [2]. Eur J Pharmacol . 2011 Jul 1;661(1-3):57-62. [3]. Neuropharmacology . 2004 May;46(6):888-94. [4]. J Ocul Pharmacol Ther . 2002 Oct;18(5):475-88. |
||
| Additional Infomation | Pemirolast Potassium is the potassium salt form of pemirolast, a pyrimidinone derivative with antiallergic property. Pemirolast potassium exerts its action by blocking the antigen-mediated calcium ion influx into mast cells. This prevents mast cell degranulation, resulting in mast cell stabilization and inhibition of the release of inflammatory mediators, histamine and leukotrienes, which are involved in the allergic process. Pemirolast potassium also prevents inflammatory mediator release from eosinophils. |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (375.52 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7552 mL | 18.7758 mL | 37.5516 mL | |
| 5 mM | 0.7510 mL | 3.7552 mL | 7.5103 mL | |
| 10 mM | 0.3755 mL | 1.8776 mL | 3.7552 mL |